Neil Wasserman
Internal Medicine · New Britain, CTNPI 1285621250
Payments from drug & device makers
Across 175 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$467
- Pfizer$375
- AbbVie$308
- Johnson & Johnson$165
- Amarin Pharma, Inc.$162
- GSK$145
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,76499%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 23 | $467 |
| Pfizer | 27 | $375 |
| AbbVie(2 entities) | 15 | $308 |
| Johnson & Johnson | 16 | $165 |
| Amarin Pharma, Inc. | 11 | $162 |
| GSK | 8 | $145 |
| Novo Nordisk | 6 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $115 |
| Astellas Pharma US Inc | 8 | $99 |
| AstraZeneca | 7 | $90 |
| Sanofi Pasteur Inc. | 5 | $80 |
| Lilly USA, LLC | 5 | $75 |
| Abbott | 4 | $73 |
| Amgen | 4 | $69 |
| Merck | 5 | $69 |
| Scilex Pharmaceuticals Inc. | 3 | $57 |
| Shire North American Group Inc | 3 | $49 |
| Hikma Pharmaceuticals USA | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Eisai Inc. | 2 | $35 |
| Genentech USA, Inc. | 2 | $26 |
| Collegium Pharmaceutical, Inc. | 2 | $25 |
| Bayer | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
How this compares
$2,804 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine | 12 | $597 |
| Levothyroxine Sodium | 12 | $164 |
| Pantoprazole Sodium | 12 | $160 |
| Furosemide | 13 | $67 |
| Omeprazole | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New Britain
- Joseph SouferWaterbury$21.5M
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Michelle MallitzTrumbull$971K
- Allen HellerWoodbridge$758K
- Gary BlickNorwalk$717K
- Margaret ChusteckaHamden$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.